Summa Equity acquires Finnish antibody manufacturer HyTest
Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry. The growing company operates in a global market where growth is driven by an aging population, innovation and increasing investments in medical care. The investment is Summa Equity’s first in the Finnish market.”Antibodies and antigens make it possible to diagnose and follow disease development using in vitro diagnostics (IVD). Use of this technology will increase with an aging population, continued advances in research and technology, and the global